Journals / Acta Odontologica Turcica / 2020 / Cilt: 37 - Sayı: 2

Assessment of the frequency of hepatitis A, B, C and HIV infections in dental patients of Kocaeli University, Faculty of Dentistry

Kocaeli Üniversitesi Diş Hekimliği Fakültesine başvuran hastalarda hepatit A, B, C ve HIV enfeksiyon sıklığının değerlendirilmesi

Pages
36–41
Publication Date
2020-05-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These patients were scheduled in the clinic 54,328 times for dental treatment procedures.Conclusion: Increasing awareness of patients, dentists, and dental assistants about infectious viral diseases will reduce the risk of direct and indirect cross-infection-related transmissions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Dental practitioners are constantly in contact with blood and saliva, and therefore they are in a high-risk group.
📊
Key Findings & Data:The objective of this study was to examine the prevalence of hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV) and Human Immunodeficiency Virus (HIV) infections in patients who applied to the Kocaeli University, Faculty of Dentistry.Materials and Method: This study included the retrospective analysis of the anamnesis files of patients who had been admitted to the Kocaeli University, Faculty of Dentistry, between the dates 17.04.2013 and 10.05.2019.
💡
Conclusion & Impact:These patients were scheduled in the clinic 54,328 times for dental treatment procedures.Conclusion: Increasing awareness of patients, dentists, and dental assistants about infectious viral diseases will reduce the risk of direct and indirect cross-infection-related transmissions.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Diş hekimliği · hepatit A · hepatit B

Abstract

Objective: Dental practitioners are constantly in contact with blood and saliva, and therefore they are in a high-risk group. The objective of this study was to examine the prevalence of hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV) and Human Immunodeficiency Virus (HIV) infections in patients who applied to the Kocaeli University, Faculty of Dentistry.Materials and Method: This study included the retrospective analysis of the anamnesis files of patients who had been admitted to the Kocaeli University, Faculty of Dentistry, between the dates 17.04.2013 and 10.05.2019. The total number of cases with a history of HAV, HBV, HCV, and HIV, their distribution by gender, age, and the number of dental treatment visits of these patients were determined.Results: A total of 180,655 anamnesis files were examined. One thousand eight hundred nine patients with a history of HAV, HBV, HCV, and HIV were identified; 103 (0.057%) patients had HAV, 1,575 (0.871%) had HBV, 103 (0.057%) had HCV and 28 (0.015%) had HIV. These patients were scheduled in the clinic 54,328 times for dental treatment procedures.Conclusion: Increasing awareness of patients, dentists, and dental assistants about infectious viral diseases will reduce the risk of direct and indirect cross-infection-related transmissions.

Özet

Amaç: Diş hekimliği çalışanları sürekli olarak kan ve tükürük ile temas halindedir ve bu nedenle yüksek risk grubu arasında yer almaktadırlar. Bu çalışmanın amacı, Kocaeli Üniversitesi Diş Hekimliği Fakültesine başvuran hastalardaki Hepatit A virüs (HAV), Hepatit B virüs (HBV), Hepatit C virüs (HCV) ve İnsan İmmun Yetmezlik Virüsü (HIV) görülme sıklığını belirlemektir. Gereç ve Yöntem: Bu araştırma, 17.04.2013 - 10.05.2019 tarihleri arasında Kocaeli Üniversitesi Diş Hekimliği Fakültesine başvuran 180655 hastanın anamnez dosyalarının incelenmesi yoluyla retrospektif olarak yapıldı. HAV, HBV, HCV ve HIV öyküsü olan toplam vaka sayıları, cinsiyetlere ve yaşlara göre olan dağılımları ve bu enfekte hastaların dental tedavi işlemleri için toplam kaç kez fakülteye geldikleri tespit edildi.Bulgular: Çalışma için toplamda 180,655 kişinin anamnez dosyası incelendi. HAV, HBV, HCV ve HIV öyküsü olan 1,809 hasta tespit edildi. Bunlar arasında 103 (%0.057) hasta HAV, 1,575 (%0.871) hasta HBV, 103 (%0.057) hasta HCV ve 28 (%0.015) hasta HIV öyküsüne sahipti. Bu hastaların dental tedavi işlemleri için kliniklere 54,328 kez başvurduğu tespit edildi.Sonuç: Hastalar, diş hekimleri ve diş hekimi asistanlarının bulaşıcı viral hastalıklar konusundaki farkındalığının arttırılması, doğrudan ve dolaylı çapraz enfeksiyonla ilişkili bulaşma riskini azaltacaktır.

🔖

Cite This Article

HOŞGÖR, H. (2020). Assessment of the frequency of hepatitis A, B, C and HIV infections in dental patients of Kocaeli University, Faculty of Dentistry. Acta Odontologica Turcica, Cilt: 37 - Sayı: 2, 36–41. https://ajindex.com/articles/265302

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Kohn WG, Collins AS, Cleveland JL, Harte JÁ, Eklund KJ, Malvitz DM. Guidelines for infection control in dental health care settings. MMWR Recommendations Rep 2003;52:1-61.
  2. Tekin Koruk S, Koruk İ, Şahin M, Duygu F. Evaluation of HBsAg, anti-HBs and anti-HCV positivity and risk factors among oral and dental health workers in Şanlıurfa. Klimik Journal 2009;22:55-61.
  3. Siew C, Gruninger S, Chang SB, Clayton R. Seroprevalence of hepatitis B and HIV infection among oral surgeons. J Dent Res 1994;73(Suppl):281. Mbaisi EM, Wanzala P, Omolo J. Prevalence and factors associated with percutaneous injuries and splash exposures among health-care workers in a provincial hospital, Kenya, 2010. Pan Afr Med J 2013;14:10. Gündüz F, Güney Duman D. Karaciğer Hastalıkları. In: Gürler EB, editor. Diş Hekimliği Bakış Açısıyla Sistemik Hastalıklar. İstanbul: Quintessence Publishing; 2017. p. 89-93.
  4. Dienstag JL, Delemos AS. Viral hepatitis. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 8th ed. Philadelphia: Elsevier Saunders; 2015. p. 1441-67.
  5. Curry MP, Chopra S. Acute viral hepatitis. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2005. p. 1426-41. WHO Position Paper on Hepatitis A Vaccines – June 2012. Wkly Epidemiol Rec 2012;87:261-76. Koff RS. Hepatitis A. Lancet 1998;351:1643-9.
  6. Akhan S, Aynıoğlu A, Çağatay A, Gönen İ, Günal Ö, Kaynar T, et al. Kronik Hepatit B Virüsü İnfeksiyonunun Yönetimi: Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Viral Hepatit Çalışma Grubu Uzlaşı Raporu. Klimik Dergisi 2014;27:2-18.
  7. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of Worldwide Prevalence of Chronic Hepatitis B Virus Infection: a Systematic Review of Data Published Between 1965 and 2013. Lancet 2015;386:1546-55.
  8. Poynard T, Man-Fung Y, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003;362:2095-100.
  9. Kaya Ş, Baysal B, Temiz H, Karadağ Ö, Özdemir K, Bilman F. Seroprevalence of hepatitis B and C among patients admitted to a tertiary hospital. Viral Hepat J 2014;20:120-4.
  10. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013;57:1333-42.
  11. Ackerman Z, Ackerman E, Paltiel O. Intrafamilial transmission of hepatitis C virus: a systematic review. J Viral Hepat 2000;7:93-103.
  12. Martins T, Narciso-S